ONCare Specialty Consultants’ Post

An obvious near future implementation of this work is in drug development pipelines. By modeling out a limited number of likely proteins to test for efficacy, the cost and efficiency in bringing new drugs to animal/cell models, clinical trials and eventually marketplace for routine use, can be reduced tremendously. The historic models have been to do trial and error testing on hundreds if not thousands of potential protein iterations of potential therapeutics, which costs huge amounts and takes years of development. Limiting the number of proteins to be tested, by modeling the most likely to be successful, these cost and time savings could be realized and change the entire face of drug development from its current paradigm. Perhaps, paired with legislative incentives, these savings could make their way into savings for consumers?

These are needed and obvious changes and this is a well worded notification that these times are here. The difficulty for a patient is in figuring out how, once aware that they can and often should feel appropriate about wanting to be engaged and advocate for themselves, how to do so. Direct patient navigation, education and advocacy are critical to help move this shift and patient expectation forward. Out of necessity evolves innovation and we are excited to dynamically be offering such services to fill/resolve new gaps and trends. Patients should be confident and educated enough to engage in their own treatment decision making moreso than has been historically routine.

The mounting evidence and thought related to the microbiome and it's extended association with the oral flora population, is almost intuitive. This topic represents a huge potential opportunity to better address disease prevention, treatment effectiveness and wellness. Of ocurse, publications like this merit further investigation and study to clarify possible cause and effect relationships with a hopeful eye to possible interventions for all.

These are needed and obvious changes and this is a well worded notification that these times are here. The difficulty for a patient is in figuring out how, once aware that that can and often should feel appropriate about wanting to be engaged and advocate for themselves, how to do so. Direct patient navigation, education and advocacy are critical to help move this shift and patient expectation forward. Out of necessity evolves innovation and we are excited to dynamically be offering such services to fill/resolve new gaps and trends. Patients should be confident and educated enough to engage in their own treatment decision making moreso than has been historically routine.

When providers are confident and knowledgeable about specific integrative modalities to help support patients, many patients will experience a more communicative and trusting care based relationship. The more integrative we as care providers can be to meet our unique patients where they are, beyond the trauma of a new cancer diagnosis, the better we are able comfort and customize care plans for and with them.

Quite interesting and seemingly logical. Worth studying and keeping mind when there’s a simple life hack that could be potentially this significant.

Self awareness, stress regulation, connectivity, and identification of the sources of joy and fulfillment are related but not solely dependent on financial fitness. A refreshing discussion on what quality of life means today.

https://lnkd.in/eqNGVdJw Monday monring blast of interesting, significant and helpful health news updates in Oncology: This is a great review and tool to update both care providers, treating physicians, and most importantly patients themselves. Note please that the paradigms are changing and that less is often more, in the current setting of breast radiation schedules. Having options to better cater to and personalize each patients' actual treatments to help truncate their treatment journey, is wonderful to be aware of. If able, advocate for yourself as an educated consumer of care, just as one might when shopping for any other large purchase or interest. Asking about all options should be easy and standard, and at minimum a baby step towards putting the patient back in the virtual driver's seat of treatment design.

https://lnkd.in/eDxiJ4h7 Would love to understand moreso where these extra billions are actually to come from? Glad to see some meaningful efforts made on this medical debt front for patients. However, hospitals and anyone benefittitng from these bailouts should be held acutely accountable for earmarking the funds both which are used to accrue costs as well as where the moneys go to relieve these debts. If these funds are used to translate to ceo and md salaries at elevated rates, then how is this not like the bailouts in other industries which are “too big to fail?”

Atop all other pressing concerns in the world today, this is truly an alarming one worth trying best to understand and address with meaningful interventions. Obviously detecting these diseases at the earliest possible opportunity is immediately critical. But to the larger context, better understanding the potential etiologies and variables which may contribute, is paramount so as to prevent this trend from becoming the new norm. https://lnkd.in/e7-MCxY7